Research paths
CME GROUP INC.
CME GROUP INC. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q1 2026 .
Symbol
CME on Nasdaq
Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
24 Apr 2026
Shareable Research Card
CME - CME GROUP INC. Financial Facts
CME - CME GROUP INC. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.
Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.
Context
Latest metrics period: Q1 2026
Latest reported value
Return On Equity 16%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Return Loop
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
Latest source-backed update
Latest metrics period Q1 2026
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
Current latest metrics period: Q1 2026.
Most recent SEC facts end date on this page: 31 Mar 2026.
Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for CME - CME GROUP INC.
New fact period available
Latest financial period: Q1 2026. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
24 Apr 2026
Page type
Company facts
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 24 Apr 2026.
Benchmark Context
How Return On Equity compares
Return On Equity is up about 19% versus the comparable prior period.
Compared with
Compared with CME GROUP INC.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
Latest comparable period on this page: Q1 2026.
Peer context will appear when enough companies report a comparable value for this metric.
Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
How to read key metrics on this page
These short guides explain what the headline metrics mean, what to compare next, and where to open the live SEC-backed example for this company.
Plain-English Guide
How to read Revenue on this page
Revenue is the sales a company reports from customers before most expenses are subtracted.
Why people care
People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.
How to read it
Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.
Compare next
Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.
Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.
Open a live SEC-backed example
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Quick Takeaways
CME - CME GROUP INC. financial facts are built from SEC company filings data.
Latest metrics period on this page: Q1 2026.
Headline metric: Return On Equity 16%.
What Changed
Return On Equity YoY change: +19%.
Most recent SEC facts end date: 31 Mar 2026.
Why This Matters
This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
Every metric card links to a deeper SEC-backed history page for verification.
Source Evidence
Based on latest 10-Q/10-K
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
See Original Filing
Latest SEC snapshot (2026-03-31) highlights Return On Equity 15.9%, Return On Assets 1.6%, and Operating Margin 69.8%.
Compare This Company Through SEC-backed Metrics
Use these links to compare CME - CME GROUP INC. against other SEC filers on the same metric, then verify the company history from the paired facts page.
Revenues YoY
Latest value: 7.5%
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
57.2/100
Caution
Confidence medium
Return On Equity
16%
Metric score 46.6/100
Return On Assets
1.6%
Metric score 0.0/100
Financial Health
Current Ratio
1.02x
Quick Ratio
0.02x
Debt to Equity
0.14x
Strengths
Operating Margin, Current Ratio, and Debt-to-equity
Watchpoints
Return On Assets and Quick Ratio
Growth
Metric
Latest value
YoY change
Calendar period
Fiscal period
Unit
Revenues YoY
7.5%
Q1 2026
Q1 2026
%
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
Metric
Latest value
YoY change
Calendar period
Fiscal period
Unit
Accounts Payable, Current
$75,400,000
-25%
Q1 2026
Q1 2026
USD
Accounts Receivable, after Allowance for Credit Loss, Current
$935,500,000
+21%
Q1 2026
Q1 2026
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
$59,400,000
Q1 2026
Q1 2026
USD
Amortization of Intangible Assets
$224,300,000
+1.2%
Q1 2026
Q1 2026
USD
Assets
$201,993,500,000
+28%
Q1 2026
Q1 2026
USD
Assets, Current
$169,001,200,000
+37%
Q1 2026
Q1 2026
USD
Cash and Cash Equivalents, at Carrying Value
$2,391,200,000
+70%
Q1 2026
Q1 2026
USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
$167,432,900,000
+37%
Q1 2026
Q1 2026
USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
$3,353,400,000
-83%
Q1 2026
Q1 2026
USD
Costs and Expenses
$2,327,200,000
+5.6%
Q1 2026
Q1 2026
USD
Deferred Income Tax Expense (Benefit)
$13,400,000
-81%
Q1 2026
Q1 2026
USD
Deferred Income Tax Liabilities, Net
$5,221,100,000
-0.36%
Q1 2026
Q1 2026
USD
Depreciation
$27,200,000
-0.37%
Q1 2026
Q1 2026
USD
Earnings Per Share, Basic
11.8
+18%
Q1 2026
Q1 2026
USD/shares
Earnings Per Share, Diluted
11.72
+18%
Q1 2026
Q1 2026
USD/shares
Goodwill
$10,506,000,000
+0.06%
Q1 2026
Q1 2026
USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
$5,596,600,000
+20%
Q1 2026
Q1 2026
USD
Income Tax Expense (Benefit)
$1,326,300,000
+27%
Q1 2026
Q1 2026
USD
Increase (Decrease) in Accounts Receivable
$295,800,000
+50%
Q1 2026
Q1 2026
USD
Lessee, Operating Lease, Liability, to be Paid
$311,800,000
-18%
Q1 2026
Q1 2026
USD
Lessee, Operating Lease, Liability, to be Paid, Year Four
$32,200,000
-10%
Q1 2026
Q1 2026
USD
Lessee, Operating Lease, Liability, to be Paid, Year One
$49,500,000
-8.3%
Q1 2026
Q1 2026
USD
Lessee, Operating Lease, Liability, to be Paid, Year Three
$33,200,000
-27%
Q1 2026
Q1 2026
USD
Lessee, Operating Lease, Liability, to be Paid, Year Two
$43,800,000
-6.6%
Q1 2026
Q1 2026
USD
Liabilities
$175,375,300,000
+34%
Q1 2026
Q1 2026
USD
Liabilities and Equity
$201,993,500,000
+28%
Q1 2026
Q1 2026
USD
Liabilities, Current
$165,997,800,000
+37%
Q1 2026
Q1 2026
USD
Marketable Securities, Current
$124,200,000
+9%
Q1 2026
Q1 2026
USD
Net Cash Provided by (Used in) Financing Activities
$2,116,500,000
-89%
Q1 2026
Q1 2026
USD
Net Cash Provided by (Used in) Investing Activities
$23,000,000
-44%
Q1 2026
Q1 2026
USD
Net Cash Provided by (Used in) Operating Activities
$1,259,900,000
+13%
Q1 2026
Q1 2026
USD
Nonoperating Income (Expense)
$1,165,400,000
+97%
Q1 2026
Q1 2026
USD
Operating Income (Loss)
$4,431,200,000
+8.6%
Q1 2026
Q1 2026
USD
Operating Lease, Liability
$270,500,000
-15%
Q1 2026
Q1 2026
USD
Operating Lease, Liability, Current
$46,200,000
+6.2%
Q1 2026
Q1 2026
USD
Operating Lease, Liability, Noncurrent
$224,300,000
-19%
Q1 2026
Q1 2026
USD
Operating Lease, Payments
$58,300,000
-21%
Q1 2026
Q1 2026
USD
Operating Lease, Right-of-Use Asset
$198,700,000
-11%
Q1 2026
Q1 2026
USD
Other Assets, Current
$515,000,000
+12%
Q1 2026
Q1 2026
USD
Other Assets, Noncurrent
$2,404,800,000
-33%
Q1 2026
Q1 2026
USD
Other Liabilities, Noncurrent
$733,200,000
+1.7%
Q1 2026
Q1 2026
USD
Other Noncash Income (Expense)
$11,100,000
Q1 2026
Q1 2026
USD
Payments to Acquire Property, Plant, and Equipment
$21,800,000
+54%
Q1 2026
Q1 2026
USD
Property, Plant and Equipment, Net
$355,400,000
-4.3%
Q1 2026
Q1 2026
USD
Retained Earnings (Accumulated Deficit)
$4,884,600,000
+4.2%
Q1 2026
Q1 2026
USD
Share-based Payment Arrangement, Noncash Expense
$21,800,000
+2.8%
Q1 2026
Q1 2026
USD
Stockholders' Equity Attributable to Parent
$26,618,200,000
-1.5%
Q1 2026
Q1 2026
USD
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
Metric
Weight
V1 threshold
ROIC 20 5% to 20%
ROE 15 8% to 25%
ROA 10 2% to 10%
Operating Margin 5 5% to 25%
Current Ratio 12 1.0x to 2.0x
Quick Ratio 8 0.8x to 1.5x
Debt to Equity 10 0.3x to 2.0x (lower is better)
Revenue YoY 10 -10% to +20%
Net Income YoY 10 -10% to +20%
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
TTM Operating Income / TTM Revenues
Current Assets / Current Liabilities (latest instant quarter)
(Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
TTM Revenues YoY
TTM Net Income YoY
Explore related SEC datasets